Tough on the tumor

Easier on you and your caregivers

Get a head STaRT in the fight against brain tumors

A radiation treatment specifically designed for use inside the brain, GammaTile Therapy gives patients new hope in the fight against brain tumors. It can eliminate the need for traditional repeat radiation treatments and associated hospital or clinic visits, so patients can focus on what matters most—healing.

The neurosurgeon places GammaTile(s) precisely where and when treatment will help the most—immediately after tumor removal.

Radiation is focused right where it is needed and away from healthy brain tissue.[1]

GammaTile is designed to protect healthy brain tissue, limiting side effects from radiation.[1-4]

There is no need for an extra hospital stay, additional copays, or travel for ongoing radiation treatments.

Get a head STaRT in the fight against brain tumors. 

Find a GammaTile Therapy Center near you.

GammaTile Therapy: Clinical Outcomes

When comparing outcomes from different clinical studies evaluating the effectiveness of GammaTile Therapy and other treatments in patients with recurrent brain tumors, GammaTile Therapy demonstrated more time spent without local tumor recurrence in patients with meningiomas and brain metastases. GammaTile Therapy also potentially improved overall survival in patients with recurrent high-grade gliomas.

Doubled Time Recurrence-Free in Treatment Area

PATIENTS WITH MENINGIOMAS AT 2 YEARS[1]

PATIENTS WITH BRAIN METASTASES AT 1 YEAR[1]

Potential to Extend Overall Survival

PATIENTS WITH HIGH-GRADE GLIOMAS AT 1 YEAR

Learn about the company that developed GammaTile Therapy.

REFERENCES 

  1. Data on file, GT Medical Technologies, Inc.

  2. Stupp R, Wong ET, Kanner AA, et al. NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment  modality. Euro J Cancer. 2012; 48(14):2192-2202.

  3. Nakaji P, Youssef E, Dardis C, Smith K, Pinnaduwage D, Brachman D. Surgically targeted radiation therapy: a prospective trial in 79 recurrent, previously irradiated intracranial neoplasms. Poster presented at: 2019 AANS Annual Scientific Meeting; April 2019; San Diego, CA. 

  4.  Brachman D, Youssef E, Dardis C, Smith K, Pinnaduwage D, Nakaji P. Surgically targeted radiation therapy: Safety profile of collagen tile brachytherapy in 79 recurrent, previously irradiated intracranial neoplasms on a prospective clinical trial. Brachytherapy. 2019;18(3):S35-S36.

TREATMENT CONSIDERATIONS 

GammaTile Therapy is intended to deliver radiation therapy in patients with newly diagnosed malignant brain tumors and recurrent brain tumors. The potential for, and symptoms of, adverse events related to radiation exposure vary depending on the radiosensitivity of the exposed tissue, the amount of radiation delivered, and the placement of GammaTile(s). Serious side effects related to GammaTile Therapy are rare, and may include radiation brain changes including necrosis. GammaTile Therapy should not be used for patients with known history of hypersensitivity to bovine-derived materials. Possible complications can occur with any neurosurgical procedure, including cerebrospinal fluid leaks, infection, delayed hemorrhage, and adhesion formation.

CONNECT WITH US
  • Twitter
  • LinkedIn
  • Facebook
  • YouTube

©2020 GT Medical Technologies, Inc. I All rights reserved | Privacy Policy | Terms of Use

IMPROVING THE LIVES OF PATIENTS WITH BRAIN TUMORS